201. Binding capacity of mannose-binding lectin (MBL) is associated with the severity of chronic Chagas cardiomyopathy.
- Author
-
Azevedo, Elisa de A.N., de Lima, Raul Emídio, Diniz, George, Morais, Clarice N.L., Gomes, Yara M., Barreto, Silvana, Moura, Patrícia M.M. de F., Teixeira, Romero Henrique, JrOliveira, Wilson, and Cavalcanti, Maria da Glória A.M.
- Subjects
- *
MANNOSE-binding lectins , *CHAGAS' disease , *BINDING agents , *CARDIOMYOPATHIES , *ENZYME-linked immunosorbent assay , *GENETICS - Abstract
Chagas disease (CD) is a global problem. Currently, it affects approximately 15 million individuals in Latin America. It is well know that the human immune response is related to different clinical manifestations. Mannose binding lectin (MBL) plays an important role in innate immunity, and it mediates the phagocytosis and complement-mediated destruction of pathogens. The binding capacity is enhanced by the oligomerization of MBL. In this study, we evaluated the serum concentration and the binding capacity of MBL in patients with chronic chagasic cardiomyopathy. A total of 77 patients with chronic CD were included with indeterminate (n = 19), mild cardiac (n = 29) and severe cardiac (n = 29) forms. The serum concentration and the binding capacity were measured using enzyme-linked immunosorbent assays (ELISA). There was no significant difference in the serum MBL levels between the groups of patients. However, we found a relationship between the binding capacity and the groups studied. Our results suggest that binding capacity of MBL could be an indicator of clinical manifestation in Chronic Chagas cardiomyopathy. Furthermore, combined with the Mannose Binding Index results in a useful clinical tool for management of Chronic Chagas Patients. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF